That's an outrageous claim, really. Geron has its master cell bank - clinical grade - and Geron and others have feeder free lines. It would be interesting to find out what fine line they've crossed to make their claim that they're the first and only.
There is nothing in it to suggest that their "product" is anything other than a cell line that researchers can try to develop therapies from... Geron does have this. In addition Geron has a telomerase based reproduction method that will make treatments affordable. Apparently ESI does not have this.
As for the G.B. connection - Roslyn is where dolly the sheep comes from and they own it. One of the researchers there actually got permission from the government to therapeutically clone a cell line for a rare disease - this isn't done very often.
Geron also has a Hong Kong partnership. I think this was done because China is really pushing for an aids cure and there is an advantage to doing the work there.
They will make partnerships abroad where they see fit, no problem.
News 
Market Data 
Discover 
AI
